JP2011500693A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500693A5
JP2011500693A5 JP2010530049A JP2010530049A JP2011500693A5 JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5 JP 2010530049 A JP2010530049 A JP 2010530049A JP 2010530049 A JP2010530049 A JP 2010530049A JP 2011500693 A5 JP2011500693 A5 JP 2011500693A5
Authority
JP
Japan
Prior art keywords
methyl
bipyrrolidinyl
phenyl
amide
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500693A (ja
JP5377503B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079757 external-priority patent/WO2009052062A1/en
Publication of JP2011500693A publication Critical patent/JP2011500693A/ja
Publication of JP2011500693A5 publication Critical patent/JP2011500693A5/ja
Application granted granted Critical
Publication of JP5377503B2 publication Critical patent/JP5377503B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530049A 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用 Expired - Fee Related JP5377503B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98059907P 2007-10-17 2007-10-17
US60/980,599 2007-10-17
PCT/US2008/079757 WO2009052062A1 (en) 2007-10-17 2008-10-14 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof

Publications (3)

Publication Number Publication Date
JP2011500693A JP2011500693A (ja) 2011-01-06
JP2011500693A5 true JP2011500693A5 (enExample) 2011-12-01
JP5377503B2 JP5377503B2 (ja) 2013-12-25

Family

ID=40247942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530049A Expired - Fee Related JP5377503B2 (ja) 2007-10-17 2008-10-14 置換されたn−フェニル−ビピロリジンカルボキサミド及びその治療上の使用

Country Status (25)

Country Link
US (2) US8088808B2 (enExample)
EP (1) EP2212283B1 (enExample)
JP (1) JP5377503B2 (enExample)
KR (1) KR20100072077A (enExample)
CN (1) CN101903340B (enExample)
AT (1) ATE525351T1 (enExample)
AU (1) AU2008312635B2 (enExample)
BR (1) BRPI0818581A2 (enExample)
CA (1) CA2702467C (enExample)
CY (1) CY1112083T1 (enExample)
DK (1) DK2212283T3 (enExample)
ES (1) ES2372332T3 (enExample)
HR (1) HRP20110762T1 (enExample)
IL (1) IL205001A (enExample)
MA (1) MA31858B1 (enExample)
MX (1) MX2010003949A (enExample)
MY (1) MY151348A (enExample)
NZ (1) NZ584690A (enExample)
PL (1) PL2212283T3 (enExample)
PT (1) PT2212283E (enExample)
RS (1) RS52235B (enExample)
RU (1) RU2477720C2 (enExample)
SI (1) SI2212283T1 (enExample)
WO (1) WO2009052062A1 (enExample)
ZA (1) ZA201002115B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2477721C2 (ru) 2007-10-17 2013-03-20 Санофи-Авентис Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
RS52235B (sr) * 2007-10-17 2012-10-31 Sanofi Supstituisani n-fenil-bipirolidin karboksamidi i njihova terapeutska upotreba
ES2378011T3 (es) 2007-10-17 2012-04-04 Sanofi N-fenil-bipirrolidin ureas sustituidas y uso terapéutico de las mismas
HRP20110953T1 (hr) 2007-10-17 2012-01-31 Sanofi Supstituirani n-fenilbipirolidinkarboksamidi i njihova upotreba u terapiji
AR074467A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Tetrahidropiran espiro pirrolidinonas y piperidinonas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento y/o prevencion de enfermedades del snc ,tales como alzheimer y parkinson, entre otras.
AR074466A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
SA110310332B1 (ar) 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
AR083718A1 (es) 2010-05-11 2013-03-20 Sanofi Aventis Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas
JP5833105B2 (ja) 2010-05-11 2015-12-16 サノフイ 置換n−ヘテロアリールスピロラクタムビピロリジン類、その製造及び治療的使用
TW201206901A (en) * 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
JP5766278B2 (ja) 2010-05-11 2015-08-19 サノフイ 置換されたn−アルキルおよびn−アシルテトラヒドロ−イソキノリン誘導体、それらの製造および治療上の使用
WO2011143163A1 (en) * 2010-05-11 2011-11-17 Sanofi Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
AR081382A1 (es) 2010-05-11 2012-08-29 Sanofi Aventis Derivados de n-heterocicloalquil bipirrolidinilfenil amida sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades del sistema nervioso central.
TW201206444A (en) * 2010-05-11 2012-02-16 Sanofi Aventis Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
PH12013500027A1 (en) * 2010-07-06 2017-10-25 Astrazeneca Ab Therapeutic agents 976
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
JP2013232564A (ja) * 2012-04-27 2013-11-14 National Institute Of Advanced Industrial & Technology 半導体装置および半導体装置の製造方法
CN108250128A (zh) * 2012-09-27 2018-07-06 江苏先声药业有限公司 作为钾通道调节剂的化合物
BR112015016394A2 (pt) 2013-01-10 2017-07-11 Gruenenthal Gmbh carboxamidas ii baseadas em pirazolil como inibidoras do canal crac
KR20150103751A (ko) 2013-01-10 2015-09-11 그뤼넨탈 게엠베하 Crac 채널 억제제로서의 피라졸릴계 카복스아미드 i
EP3366683A1 (en) 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) * 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
EP1556046A1 (en) * 2002-10-23 2005-07-27 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) * 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
US7951826B2 (en) 2005-03-17 2011-05-31 Eli Lilly And Company Pyrrolidine derivatives as histamine H3 receptor antagonists
AU2006232871B9 (en) * 2005-04-01 2011-11-24 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
JP5193033B2 (ja) * 2005-07-01 2013-05-08 イーライ リリー アンド カンパニー ヒスタミンh3受容体薬剤、製剤及び治療的使用
WO2007048595A1 (en) * 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
BRPI0707872A2 (pt) * 2006-02-15 2011-05-10 Sanofi Aventis arildiidroisoquinolinonas substituÍdas por azaciclila, processo para sua preparaÇço e seu uso como medicamentos
ES2378011T3 (es) * 2007-10-17 2012-04-04 Sanofi N-fenil-bipirrolidin ureas sustituidas y uso terapéutico de las mismas
RU2477721C2 (ru) 2007-10-17 2013-03-20 Санофи-Авентис Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
HRP20110953T1 (hr) 2007-10-17 2012-01-31 Sanofi Supstituirani n-fenilbipirolidinkarboksamidi i njihova upotreba u terapiji
RS52235B (sr) * 2007-10-17 2012-10-31 Sanofi Supstituisani n-fenil-bipirolidin karboksamidi i njihova terapeutska upotreba

Similar Documents

Publication Publication Date Title
JP2011500693A5 (enExample)
CA2702467A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
CA2702482A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
RU2010119530A (ru) Замещенные n-фенилпирролидинилметилпирролидинамиды и их терапевтическое применение в качестве модуляторов рецептора н3 гистамина
JP2005526723A5 (enExample)
JP2010526777A5 (enExample)
JP2011500697A5 (enExample)
RU2462456C2 (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2011500694A5 (enExample)
JP2005527579A5 (enExample)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
RU2011137454A (ru) Агонисты и антагонисты s1p5-рецепторов и способы их применения
NZ705710A (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
CN109503625A (zh) 一种多环吡啶酮化合物及其药物组合和用途
JP2002539206A5 (enExample)
JP2007508358A5 (enExample)
JP2006522126A5 (enExample)
JP2012515724A5 (enExample)
JP2010502716A5 (enExample)
JP2007508360A5 (enExample)
JP2012507538A5 (enExample)
BR112012015168A2 (pt) "derivados de benzamida substituída".
JP2020527175A5 (enExample)
JP2011527333A5 (enExample)
JP2010510232A5 (enExample)